Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · Invesco

Invesco Dorsey Wright Healthcare Momentum ETF (PTH)

Ticker PTH · Since 2006-10-12 · · Holdings as of Jul 31, 2026

Expense ratio
0.6%$60/yr per $10k
5-yr return
−0.8%annualized
1-yr return
+28.1%as of Dec 2025
Net assets
$235.2Mall share classes
Holdings
57

Bottom line

Is PTH a good fund? The bottom line

PTH is a managed health care sector ETF from Invesco.

Its expense ratio is 0.6% — about $60 a year on every $10,000 invested, cheaper than 77% of health care sector funds we track.

It returned +28.1% over one year, −0.8% a year over five years, +10.8% a year over ten (as of Dec 31, 2025, per its prospectus).

With $235 million in net assets and 57 holdings, its largest position is Invesco Private Prime Fund (20.8%) and the top 10 make up 59.3% of the portfolio.

What stands out

  • Low cost: cheaper than 77% of health care sector peers

What to watch

  • 5-year return in the bottom quarter of its category
  • Concentrated: top 10 holdings are 59.3% of assets
  • High turnover (239% a year) can mean more taxable distributions

Updated Nov 19, 2026

What PTH invests in

The Invesco Dorsey Wright Healthcare Momentum ETF (the Fund) seeks to track the investment results (before fees and expenses) of the Dorsey Wright Healthcare Technical Leaders TM Index (the Underlying Index).

The Fund is an index fund that seeks to track the investment results of the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, Dorsey, Wright & Associates, LLC (Dorsey Wright or the Index Provider) compiles and maintains the Underlying Index, which is composed of at least 30 securities of companies in the health care sector that have powerful relative strength or momentum characteristics. Dorsey Wright selects these securities from 2,000 of the largest constituents by market capitalization within the Nasdaq US Benchmark Index, a float adjusted market capitalization-weighted index designed to track the performance of the U.S. equity market. Relative strength is an investing technique that seeks to determine the strongest performing securities by measuring certain factors, such as a securitys relative performance against the overall market over a set…

From the fund's prospectus (filed Aug 27, 2026).

PTH performance

Fund calendar-year total returns, 2015–2025 2015: +2.3%; 2016: −12.9%; 2017: +50.1%; 2018: −0.9%; 2019: +33.8%; 2020: +67.1%; 2021: −3.0%; 2022: −20.7%; 2023: −4.4%; 2024: +2.0%; 2025: +28.1% +2% 2015 −13% 2016 +50% 2017 −1% 2018 +34% 2019 +67% 2020 −3% 2021 −21% 2022 −4% 2023 +2% 2024 +28% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
PTH+28.1%−0.8%+10.8%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full PTH performance history →

What PTH costs

On a $10,000 investment, PTH's 0.6% expense ratio costs about $60 a year. The prospectus estimates $891 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full PTH fee table →

PTH top 10 holdings

#Holding% of fund
1Invesco Private Prime Fund20.79%
2Invesco Private Government Fund6.84%
3Guardant Health, Inc.4.97%
4Roivant Sciences Ltd.4.95%
5Revolution Medicines, Inc.4.94%
6Axsome Therapeutics, Inc.4.12%
7BrightSpring Health Services, Inc.4.03%
8Liquidia Corp.3.01%
9Erasca, Inc.2.94%
10Oruka Therapeutics, Inc.2.74%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 59.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to PTH

More funds like PTH →

PTH FAQ

What is the expense ratio of PTH?
PTH's expense ratio is 0.6%, which works out to about $60 a year for every $10,000 invested. The prospectus estimates total costs of $891 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is PTH a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 77% of health care sector peers; 5-year return in the bottom quarter of its category; concentrated: top 10 holdings are 59.3% of assets; high turnover (239% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does PTH hold?
PTH's largest holdings are Invesco Private Prime Fund (20.8%), Invesco Private Government Fund (6.8%), Guardant Health, Inc. (5.0%), Roivant Sciences Ltd. (4.9%), Revolution Medicines, Inc. (4.9%). It holds 57 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is PTH's 5-year return?
PTH returned −0.8% a year over the five years ending Dec 31, 2025, and +10.8% a year over ten years. Past performance does not guarantee future results.
Who manages PTH?
PTH is offered by Invesco through Invesco Exchange-traded Fund Trust.